Sep. 19, 2022

Prof. Lietzan publishes new paper on why medical device companies rarely renew patents

Professor Erika Lietzan, the William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law at Mizzou Law, recent published a new paper, “The Case of the Missing Device Patents, or: Why Device Patents Matter,” in the Fordham Intellectual Property, Media & Entertainment Law Journal. To read Prof. Lietzen’s article, visit: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4223781

Aug. 24, 2022

Prof. Erika Lietzan Re-appointed to ACUS, Named to Best Lawyer in America List

Erika Lietzan, the William H. Pittman Professor of Law & Timothy J. Heinsz Professor of Law was recently re-appointed to a two-year term as a public members of the Administrative Conference of the United States (ACUS). ACUS is an independent federal agency dedicated to improving the administrative process through consensus-driven applied research and providing nonpartisan expert advice and recommendations for federal agency procedures. Its public members are academics, practicing lawyers, and other experts drawn from the private sector. Additionally, Professor Lietzan was named a 2022 Best Lawyer in America for her high caliber work in Biotechnology and Life…

Aug. 30, 2021

Prof. Lietzen named Best Lawyer in America in FDA and Biotechnology & Life Sciences Law

Professor Erika Lietzan has again been named a “Best Lawyer in America”  in both FDA Law and Biotechnology & Life Sciences.  This marks the eighth year in a row for FDA Law and the fourteenth year in a row for Biotechnology Law.  The Best Lawyers honor is meant to identify the top 5 percent of attorneys in the United States, and it is based on the judgment of one’s peers.  Professor Lietzan practiced law for 18 years prior to joining the University of Missouri in 2014, including eight years as a partner in the Food and Drug group of Covington…

Jan. 14, 2021

Professor Lietzan elected as a member of the CREDIMI

Professor Erika Lietzan is a “Membre Associé” at the Centre de Recherche sur le Droit Des Marchés et des Investissements Internationaux (CREDIMI), which is part of the Faculty of Laws, Economics, and Politics of Dijon, within the University of Bourgogne in Dijon, France. The CREDIMI focuses on the study of the market, its functioning, and its players, including specific sectoral markets. Professor Lietzan works with specialists in drug law and health law at the CREDIMI. She has guest lectured to students, participated in conferences (both in Dijon and virtually), co-authored (e.g., in the Yale Journal of Health Policy, Law,…